OppenheimerFunds’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

OppenheimerFunds’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$1.29M	Buy	24,860 +1,858	+8%	+$90.1K	﹤0.01%	975
2018 Q4	$905K	Sell	23,002 -460	-2%	-$21.4K	﹤0.01%	1091
2018 Q3	$1.21M	Buy	23,462 +686	+3%	+$33.6K	﹤0.01%	1047
2018 Q2	$1.07M	Buy	22,776 +3,338	+17%	+$138K	﹤0.01%	1072
2018 Q1	$690K	Buy	19,438 +2,994	+18%	+$117K	﹤0.01%	1237
2017 Q4	$717K	Buy	16,444 +7,944	+93%	+$371K	﹤0.01%	1333
2017 Q3	$445K	Buy	8,500 +720	+9%	+$40.1K	﹤0.01%	1570
2017 Q2	$455K	Buy	+7,780	New	+$404K	﹤0.01%	1550
2016 Q3	–	Sell	-164,581	Closed	-$6.28M	–	1762
2016 Q2	$6.28M	Sell	164,581 -199,210	-55%	-$8.75M	0.01%	781
2016 Q1	$15M	Sell	363,791 -264,318	-42%	-$10.9M	0.02%	640
2015 Q4	$30.5M	Buy	628,109 +73,623	+13%	+$3.27M	0.04%	450
2015 Q3	$22.2M	Buy	554,486 +340,816	+160%	+$14.9M	0.03%	510
2015 Q2	$8.57M	Buy	+213,670	New	+$7.37M	0.01%	782

Other funds holding SYNH

Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return

THLTP

Thomas H. Lee (THL) Partners Boston, Massachusetts $205M AUM 1.84% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OppenheimerFunds's SYNH Position: Q1 2019 in Review

OppenheimerFunds increased its Syneos Health, Inc. Class A Common Stock (SYNH) stake by 8.1% in Q1 2019, buying an estimated $90.1K and bringing the position to 24,860 shares worth $1.29M. The position accounts for ﹤0.01% of the portfolio, ranked #975.

OppenheimerFunds first reported a position in SYNH in Q2 2015 and has held it in 13 quarters since. The position peaked at $30.5M in Q4 2015. 262 funds tracked by Wall St. Rank hold SYNH as of Q1 2019.

OppenheimerFunds held 24,860 shares of Syneos Health, Inc. Class A Common Stock worth $1.29M as of Q1 2019.
OppenheimerFunds bought 1,858 Syneos Health, Inc. Class A Common Stock shares in Q1 2019, an estimated $90.1K.
Syneos Health, Inc. Class A Common Stock made up ﹤0.01% of OppenheimerFunds's portfolio in Q1 2019, its #975 holding.
OppenheimerFunds first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2015 and has held it in 13 quarters since.
OppenheimerFunds's Syneos Health, Inc. Class A Common Stock position peaked at $30.5M in Q4 2015.
262 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.